Olympia Pharmaceuticals Adds Gonadorelin to Its Growing Men’s Hormone Portfolio

Gonadorelin 1 mg/mL injectionPositive

AI Analysis

Summary

Olympia Pharmaceuticals launched a ready-to-use Gonadorelin 1 mg/mL injection to support endogenous testosterone production, now available across 49 states as part of its men's hormone portfolio expansion.

Importance:2/10

Sentiment:

0.50

product launchmen's healthhormone therapyinjectable

Read the original article

Published by GlobeNewswire Pharma on September 1, 2026 1:00 PM

Read Original